Neurotoxicity of MDMA: neurochemical effects.
Schmidt
C J
CJ
Merrell Dow Research Institute, Cincinnati, Ohio 45215.
Kehne
J H
JH
D015104:3,4-Methylenedioxyamphetamine / Q000031:analogs & derivatives* / Q000633:toxicity; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D015198:Designer Drugs / Q000633:toxicity*; D006892:Hydroxydopamines / Q000633:toxicity; D018817:N-Methyl-3,4-methylenedioxyamphetamine; D009498:Neurotoxins / Q000633:toxicity*; D016627:Oxidopamine; D012701:Serotonin / Q000378:metabolism
D001679:Biogenic Amines; D015198:Designer Drugs; D006892:Hydroxydopamines; D009498:Neurotoxins; D012701:Serotonin; D015104:3,4-Methylenedioxyamphetamine; D016627:Oxidopamine; D018817:N-Methyl-3,4-methylenedioxyamphetamine